AAP

Aussies wait 15 months longer than US, Europe for drugs

DRUG companies are delaying making cancer-fighting drugs and other medicines available to Australian patients because of the smaller domestic market, a new report has found.

The latest review of the Therapeutic Goods Administration has found patients are waiting up to 15 months longer than those in the United States or Europe for some drugs.

While the report said some companies had complained the TGA's processes took longer, the independent review showed approvals took an average 90 days to complete.

Among the drugs cited for unusually long waits were anti-cancer medications, at five months; cardiovascular medicines, at seven months, and some nervous system medicines, at up to 15 months.

Health Minister Sussan Ley said the review "debunks the myth that Australia is slow at approving new medicines when compared to the rest of the world".

Rather, some drugs firms were just testing new drugs first in the larger markets.


REPLAY: Palaszczuk v Frecklington in final debate

REPLAY: Palaszczuk v Frecklington in final debate

Annastacia Palaszczuk v Deb Frecklington in final election debate

Fire ant worker in Gatton court for unlicensed driving charge

Premium Content Fire ant worker in Gatton court for unlicensed driving...

A FIRE ant eradication worker has appeared in Gatton court for two charges.

Premier announces NSW-QLD border decision

Premium Content Premier announces NSW-QLD border decision

Queensland Premier Annastacia Palaszczuk announces border decision